1. Home
  2. GMED vs CYTK Comparison

GMED vs CYTK Comparison

Compare GMED & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globus Medical Inc.

GMED

Globus Medical Inc.

HOLD

Current Price

$83.19

Market Cap

11.0B

Sector

Health Care

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$72.39

Market Cap

10.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GMED
CYTK
Founded
2003
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.0B
10.7B
IPO Year
2012
2004

Fundamental Metrics

Financial Performance
Metric
GMED
CYTK
Price
$83.19
$72.39
Analyst Decision
Buy
Strong Buy
Analyst Count
14
19
Target Price
$100.42
$89.26
AVG Volume (30 Days)
1.3M
1.8M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
422.67
N/A
EPS
2.00
N/A
Revenue
$2,938,931,000.00
$13,368,000.00
Revenue This Year
$11.13
$7.37
Revenue Next Year
$6.28
$310.19
P/E Ratio
$41.27
N/A
Revenue Growth
16.65
N/A
52 Week Low
$54.17
$44.93
52 Week High
$101.40
$88.31

Technical Indicators

Market Signals
Indicator
GMED
CYTK
Relative Strength Index (RSI) 47.09 40.68
Support Level $82.01 $73.34
Resistance Level $82.23 $79.66
Average True Range (ATR) 2.06 2.14
MACD -0.56 0.07
Stochastic Oscillator 5.54 27.81

Price Performance

Historical Comparison
GMED
CYTK

About GMED Globus Medical Inc.

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: